PetVet GmbH, founded in 2015 in Plettenberg, Sauerland, developed the enzyme preparation dogenzyme for the veterinary sector based on human medical knowledge of systemic enzyme therapy (SET). In recent years, the dogenzym product line has been successfully launched and has found its place in the veterinary profession, particularly in the field of joint therapy. At the beginning of 2018, we successfully expanded our portfolio and further strengthened our market position by acquiring the PHA and LaPura product lines from PetMedical GmbH.

Corporate values
Vision of the company
As a small, medium-sized company, our aim is to offer pet owners a carefully selected range of products for the health of their pets. We rely on selected distribution channels with particularly good quality advice.
